Autonomix Medical Inc. Co... (AMIX)
Autonomix Medical Common Stock Statistics
Share Statistics
Autonomix Medical Common Stock has 2.46M shares outstanding. The number of shares has increased by -86.93% in one year.
Shares Outstanding | 2.46M |
Shares Change (YoY) | -86.93% |
Shares Change (QoQ) | 39.34% |
Owned by Institutions (%) | n/a |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 860 |
FTD / Avg. Volume | 1.14% |
Short Selling Information
The latest short interest is 81.75K, so 3.32% of the outstanding shares have been sold short.
Short Interest | 81.75K |
Short % of Shares Out | 3.32% |
Short % of Float | 4.12% |
Short Ratio (days to cover) | 6.67 |
Valuation Ratios
The PE ratio is -3.67 and the forward PE ratio is -0.43. Autonomix Medical Common Stock's PEG ratio is 0.
PE Ratio | -3.67 |
Forward PE | -0.43 |
PS Ratio | 0 |
Forward PS | 0.7 |
PB Ratio | 7.41 |
P/FCF Ratio | -8.48 |
PEG Ratio | 0 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Autonomix Medical Common Stock.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.09, with a Debt / Equity ratio of 0.13.
Current Ratio | 12.09 |
Quick Ratio | 12.09 |
Debt / Equity | 0.13 |
Debt / EBITDA | -0.07 |
Debt / FCF | -0.15 |
Interest Coverage | -94.61 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | $-3,085,200 |
Employee Count | 5 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -96.53% in the last 52 weeks. The beta is -3.59, so Autonomix Medical Common Stock's price volatility has been lower than the market average.
Beta | -3.59 |
52-Week Price Change | -96.53% |
50-Day Moving Average | 2.11 |
200-Day Moving Average | 8.07 |
Relative Strength Index (RSI) | 59.77 |
Average Volume (20 Days) | 75,122 |
Income Statement
Revenue | n/a |
Gross Profit | -81K |
Operating Income | -7.47M |
Net Income | -15.43M |
EBITDA | -15.27M |
EBIT | -15.35M |
Earnings Per Share (EPS) | -21.1 |
Balance Sheet
The company has 8.61M in cash and 1M in debt, giving a net cash position of 7.61M.
Cash & Cash Equivalents | 8.61M |
Total Debt | 1M |
Net Cash | 7.61M |
Retained Earnings | -38.97M |
Total Assets | 11.95M |
Working Capital | 9.69M |
Cash Flow
In the last 12 months, operating cash flow was -6.65M and capital expenditures -19K, giving a free cash flow of -6.67M.
Operating Cash Flow | -6.65M |
Capital Expenditures | -19K |
Free Cash Flow | -6.67M |
FCF Per Share | -7.08 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
AMIX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
The average price target for AMIX is $5, which is 121.2% higher than the current price. The consensus rating is "Buy".
Price Target | $5 |
Price Target Difference | 121.2% |
Analyst Consensus | Buy |
Analyst Count | 1 |
Scores
Altman Z-Score | -6.69 |
Piotroski F-Score | 4 |